246 related articles for article (PubMed ID: 19522023)
41. Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance.
Liu KS; Wong IO; Leung WK
World J Gastroenterol; 2016 Jan; 22(3):1311-20. PubMed ID: 26811668
[TBL] [Abstract][Full Text] [Related]
42. Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions.
Sung JJ; Leung WK; Go MY; To KF; Cheng AS; Ng EK; Chan FK
Am J Pathol; 2000 Sep; 157(3):729-35. PubMed ID: 10980112
[TBL] [Abstract][Full Text] [Related]
43. Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population.
Zhang L; Blot WJ; You WC; Chang YS; Kneller RW; Jin ML; Li JY; Zhao L; Liu WD; Zhang JS; Ma JL; Samloff IM; Correa P; Blaser MJ; Xu GW; Fraumeni JF
Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):627-30. PubMed ID: 8824365
[TBL] [Abstract][Full Text] [Related]
44. Effect of Helicobacter pylori infection on Barrett's esophagus and esophageal adenocarcinoma formation in a rat model of chronic gastroesophageal reflux.
Liu FX; Wang WH; Wang J; Li J; Gao PP
Helicobacter; 2011 Feb; 16(1):66-77. PubMed ID: 21241415
[TBL] [Abstract][Full Text] [Related]
45. Helicobacter pylori infection and precancerous lesions of the stomach.
Haziri A; Juniku-Shkololli A; Gashi Z; Berisha D; Haziri A
Med Arh; 2010; 64(4):248-9. PubMed ID: 21246927
[TBL] [Abstract][Full Text] [Related]
46.
Panarese A; Galatola G; Armentano R; Pimentel-Nunes P; Ierardi E; Caruso ML; Pesce F; Lenti MV; Palmitessa V; Coletta S; Shahini E
World J Gastroenterol; 2020 Jul; 26(26):3834-3850. PubMed ID: 32774061
[TBL] [Abstract][Full Text] [Related]
47. Effect of probiotics and triple eradication therapy on the cyclooxygenase (COX)-2 expression, apoptosis, and functional gastric mucosal impairment in Helicobacter pylori-infected Mongolian gerbils.
Brzozowski T; Konturek PC; Mierzwa M; Drozdowicz D; Bielanski W; Kwiecien S; Konturek SJ; Stachura J; Pawlik WW; Hahn EG
Helicobacter; 2006 Feb; 11(1):10-20. PubMed ID: 16423085
[TBL] [Abstract][Full Text] [Related]
48. Cancer precursor lesions in intact stomach Helicobacter pylori gastritis and in resected stomach gastritis.
Giuliani A; Spada S; Corona M; Demoro M; Di Bari M; Ricciardulli T; Galati G; Caporale A; Tocchi A; Angelico F
J Exp Clin Cancer Res; 2003 Sep; 22(3):371-8. PubMed ID: 14582693
[TBL] [Abstract][Full Text] [Related]
49. Effect of Helicobacter pylori infection on Bax protein expression in patients with gastric precancerous lesions.
Liu HF; Liu WW; Wang GA; Teng XC
World J Gastroenterol; 2005 Oct; 11(37):5899-901. PubMed ID: 16270406
[TBL] [Abstract][Full Text] [Related]
50. Effect of celecoxib on E-cadherin, VEGF, Microvessel density and apoptosis in gastric cancer.
Zhou Y; Ran J; Tang C; Wu J; Honghua L; Xingwen L; Ning C; Qiao L
Cancer Biol Ther; 2007 Feb; 6(2):269-75. PubMed ID: 17224647
[TBL] [Abstract][Full Text] [Related]
51. Anti-cancer effects of COX-2 inhibitors and their correlation with angiogenesis and invasion in gastric cancer.
Fu SL; Wu YL; Zhang YP; Qiao MM; Chen Y
World J Gastroenterol; 2004 Jul; 10(13):1971-4. PubMed ID: 15222049
[TBL] [Abstract][Full Text] [Related]
52. Gastric precancerous lesions and Helicobacter pylori infection in relatives of gastric cancer patients from Northeastern Brazil.
Motta CR; Cunha MP; Queiroz DM; Cruz FW; Guerra EJ; Mota RM; Braga LL
Digestion; 2008; 78(1):3-8. PubMed ID: 18689994
[TBL] [Abstract][Full Text] [Related]
53. Induction but not inhibition of COX-2 confers human lung cancer cell apoptosis by celecoxib.
Ramer R; Walther U; Borchert P; Laufer S; Linnebacher M; Hinz B
J Lipid Res; 2013 Nov; 54(11):3116-29. PubMed ID: 23943857
[TBL] [Abstract][Full Text] [Related]
54. [Effect of Helicobacter pylori infection and eradication on proliferative kinetics of the gastric mucosa].
Unger Z; Prónai L; Szaleczky E; Zágoni T; Molnár B; Tulassay Z
Orv Hetil; 2000 Dec; 141(50):2695-700. PubMed ID: 11189675
[TBL] [Abstract][Full Text] [Related]
55. Celecoxib inhibits apurinic/apyrimidinic endonuclease-1 expression and prevents gastric cancer in Helicobacter pylori-infected mongolian gerbils.
Futagami S; Kawagoe T; Horie A; Shindo T; Hamamoto T; Suzuki K; Kusunoki M; Miyake K; Gudis K; Tsukui T; Crowe SE; Sakamoto C
Digestion; 2008; 78(2-3):93-102. PubMed ID: 18987470
[TBL] [Abstract][Full Text] [Related]
56. Combination of sulindac and antimicrobial eradication of Helicobacter pylori prevents progression of gastric cancer in hypergastrinemic INS-GAS mice.
Lee CW; Rickman B; Rogers AB; Muthupalani S; Takaishi S; Yang P; Wang TC; Fox JG
Cancer Res; 2009 Oct; 69(20):8166-74. PubMed ID: 19826057
[TBL] [Abstract][Full Text] [Related]
57. Inhibitory effect of etodolac, a selective cyclooxygenase-2 inhibitor, on stomach carcinogenesis in Helicobacter pylori-infected Mongolian gerbils.
Magari H; Shimizu Y; Inada K; Enomoto S; Tomeki T; Yanaoka K; Tamai H; Arii K; Nakata H; Oka M; Utsunomiya H; Tsutsumi Y; Tsukamoto T; Tatematsu M; Ichinose M
Biochem Biophys Res Commun; 2005 Aug; 334(2):606-12. PubMed ID: 16009342
[TBL] [Abstract][Full Text] [Related]
58. Promoter methylation of p16 associated with Helicobacter pylori infection in precancerous gastric lesions: a population-based study.
Dong CX; Deng DJ; Pan KF; Zhang L; Zhang Y; Zhou J; You WC
Int J Cancer; 2009 Jan; 124(2):434-9. PubMed ID: 18821580
[TBL] [Abstract][Full Text] [Related]
59. [Expressions of connexin 32 and connexin 43 in patients with gastric precancerous lesion after eradication of Helicobacter pylori].
Jia Y; Xu CX; Yang WB
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 33(7):628-33. PubMed ID: 18667778
[TBL] [Abstract][Full Text] [Related]
60. Pilot randomized phase II study of celecoxib in oral premalignant lesions.
Papadimitrakopoulou VA; William WN; Dannenberg AJ; Lippman SM; Lee JJ; Ondrey FG; Peterson DE; Feng L; Atwell A; El-Naggar AK; Nathan CO; Helman JI; Du B; Yueh B; Boyle JO
Clin Cancer Res; 2008 Apr; 14(7):2095-101. PubMed ID: 18381950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
